Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Am J Ophthalmol. 2021 Apr 15;228:165–173. doi: 10.1016/j.ajo.2021.03.037

Table 3.

Characteristics of Cases with Varicella Zoster Anterior Uveitis with and without Aqueous Polymerase Chain Reaction Testing for Varicella Zoster Virus

Characteristic Without PCR* Testing With PCR* Testing P-value
Number cases 98 25
Demographics
Age, median, years (25th 75th percentile) 66 (56, 74)  55 (50, 70) 0.07
Age category, years (%) 0.13
 ≤16 2 0
 17–50 12 24
 51–60 25 32
 >60 61 44
Gender (%) 0.16
 Men 37 52
 Women 63 48
Race/ethnicity (%) 0.01
 White, non-Hispanic 81 52
 Black, non-Hispanic 3 4
 Hispanic 3 0
 Asian, Pacific Islander 10 20
 Other 1 8
 Missing/unknown 2 16
Uveitis History
Uveitis course (%) 0.62
 Acute, monophasic 34 46
 Acute, recurrent 5 8
 Chronic 42 38
 Indeterminate 18 8
Laterality (%) 0.91
 Unilateral 96 96
 Bilateral 4 4
Ophthalmic examination
Cornea 0.74
 No keratitis 71 68
 Keratitis 29 32
Keratic precipitates (%) 0.63
 None 31 28
 Fine 44 36
 Round 9 16
 Stellate 4 0
  Mutton Fat 11 20
 Other 1 0
Anterior chamber cells (%) 0.33
 Grade ½+ 32 8
 1+ 37 16
 2+ 23 48
 3+ 4 20
Anterior chamber flare (%) 0.76
 Grade 0 54 60
 1+ 36 28
 2+ 10 12
Iris (%)
 Normal 83 64 0.06
 Posterior synechiae 6 8 0.66
 Sectoral iris atrophy 9 16 0.25
 Other iris abnormality 6 24 0.001
Intraocular pressure (IOP), involved eyes
 Median, mm Hg (25th, 75th percentile) 15 (12, 20)  16 (14, 30) 0.12
 Percent patients with IOP>24 mm Hg either eye 21 36 0.29
Vitreous cells (%) 0.08
 Grade 0 89 84
 ½+ 10 8
 ≥1+ 1 8
Immune compromised host (%) 8 5 0.22
Dermatomal Herpes zoster (%) 98 40 <0.0001
*

PCR = polymerase chain reaction; testing for varicella zoster virus in aqueous.